Ligand validation:7LAN

XS1: 7-[(3R,4S,6S,10R)-4-benzyl-2-oxa-7,13,14-triazatetracyclo[14.3.1.1~3,6~.1~11,14~]docosa-1(20),11(21),12,16,18-pentaen-10-yl]-3H-[1,2,3]triazolo[4,5-b]pyridin-5-amine

XS1 is a Ligand Of Interest in 7LAN designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7LAN_XS1_E_604	74%	40%	0.119	0.948	1.01	1.32	3	5	0	0	100%	1
7LAN_XS1_B_605	66%	34%	0.116	0.949	1.04	1.54	2	7	0	0	85%	0.8462
7LAN_XS1_I_605	66%	42%	0.126	0.931	0.96	1.28	2	5	0	0	100%	1
7LAN_XS1_G_605	59%	42%	0.14	0.923	0.97	1.29	3	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.